Search research articles
Contact Us
Filters
Showing results (91-100 of 237) with videos related to
Page
of 24
Sort By:
Blood
|
August 14, 2014
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis
Giovanni Palladini, Ute Hegenbart, Paolo Milani, et al.
Investigative Radiology
|
November 28, 2021
Dual-Echo Turbo Spin Echo and 12-Echo Multi Spin Echo Sequences as Equivalent Techniques for Obtaining T2-Relaxometry Data: Application in Symptomatic and Asymptomatic Hereditary Transthyretin Amyloidosis as a Surrogate Disease
Anysia Poncelet, Markus Weiler, Ute Hegenbart, et al.
Open Heart
|
July 18, 2023
Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy
Matthias Aurich, Julian Bucur, Johannes A Vey, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
December 6, 2011
Rapid assessment of longitudinal systolic left ventricular function using speckle tracking of the mitral annulus
Sebastian J Buss, Derliz Mereles, Mostafa Emami, et al.
Haematologica
|
February 22, 2008
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis
Tilmann Bochtler, Ute Hegenbart, Christiane Heiss, et al.
Elife
|
March 11, 2020
Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation
Pamina Kazman, Marie-Theres Vielberg, María Daniela Pulido Cendales, et al.
Angewandte Chemie (International Ed. in English)
|
March 9, 2016
Polymorphism of Amyloid Fibrils In Vivo
Karthikeyan Annamalai, Karl-Heinz Gührs, Rolf Koehler, et al.
Journal of Clinical Medicine
|
April 27, 2024
Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis
Fabian Aus dem Siepen, Selina Hein, Eva Hofmann, et al.
Annals of Hematology
|
December 3, 2020
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
Patrick Derigs, Aleksandar Radujkovic, Maria-Luisa Schubert, et al.
European Journal of Heart Failure
|
March 14, 2007
Non-invasive predictors of survival in cardiac amyloidosis
Arnt V Kristen, Jolanta B Perz, Stefan O Schonland, et al.
Page
of 24
Search research articles
Search
Showing results (91-100 of 237) with videos related to
Sort By:
Page
of 24
Blood
|
August 14, 2014
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis
Giovanni Palladini, Ute Hegenbart, Paolo Milani, et al.
Investigative Radiology
|
November 28, 2021
Dual-Echo Turbo Spin Echo and 12-Echo Multi Spin Echo Sequences as Equivalent Techniques for Obtaining T2-Relaxometry Data: Application in Symptomatic and Asymptomatic Hereditary Transthyretin Amyloidosis as a Surrogate Disease
Anysia Poncelet, Markus Weiler, Ute Hegenbart, et al.
Open Heart
|
July 18, 2023
Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy
Matthias Aurich, Julian Bucur, Johannes A Vey, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
December 6, 2011
Rapid assessment of longitudinal systolic left ventricular function using speckle tracking of the mitral annulus
Sebastian J Buss, Derliz Mereles, Mostafa Emami, et al.
Haematologica
|
February 22, 2008
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis
Tilmann Bochtler, Ute Hegenbart, Christiane Heiss, et al.
Elife
|
March 11, 2020
Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation
Pamina Kazman, Marie-Theres Vielberg, María Daniela Pulido Cendales, et al.
Angewandte Chemie (International Ed. in English)
|
March 9, 2016
Polymorphism of Amyloid Fibrils In Vivo
Karthikeyan Annamalai, Karl-Heinz Gührs, Rolf Koehler, et al.
Journal of Clinical Medicine
|
April 27, 2024
Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis
Fabian Aus dem Siepen, Selina Hein, Eva Hofmann, et al.
Annals of Hematology
|
December 3, 2020
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
Patrick Derigs, Aleksandar Radujkovic, Maria-Luisa Schubert, et al.
European Journal of Heart Failure
|
March 14, 2007
Non-invasive predictors of survival in cardiac amyloidosis
Arnt V Kristen, Jolanta B Perz, Stefan O Schonland, et al.
Page
of 24